Reported Diet Pill Frauds
Check your diet pill before you buy!
Article by Lim Tian Shang
Introduction
The diet pill industry is worth billions of dollars and with everything that involves huge amount of money, there are bound to be unscrupulous merchants that offer "magic pills".
"How to Avoid buying Magic Pills?"
Many of us are also confused by the large variety of diet pill brands and names. However what is really important are the active ingredients in the diet pills.
"Check the Active Ingredients!"
We are here to help by compiling a list of suspicious active ingredients that are use in diet pills, reported by government authorities and past users.
Suspicious Active Ingredient
Dexfenfluramine/Redux Ephedrine/Ephedra/Ma Huang Fenfluramine/Pondimin
Dexfenfluramine/Redux
Issued Warnings/Bans
- 1997 September 15th -- The U.S. FDA see glossary has announced the withdrawal of Dexfenfluramine. Dexfenfluramine is marketed under the brand name Redux. U.S. FDA has recommended that users to stop taking this drug.
Sources
Potential Health Risks
- Report of cardiac valvular disease (heart disease) in persons who have taken Dexfenfluramine.
Sources
Ephedrine/Ephedra/Ma Huang
Issued Warnings/Bans
- 2004 February 6th -- The U.S. FDA see glossary has issued a regulation prohibiting sale of dietary supplements containing Ephedrine Alkaloids (including Ephedrine and Pseudoephedrine) and reiterates its advice that consumers stop using these products. All dietary supplements that contain a source of Ephedrine Alkaloids such as Ephedra, Ma Huang, Sida Cordiofolia and Pinellia are included in this ban.
Sources
Potential Health Risks
- Can induce cardiac arrhythmias in susceptible people, such as those with underlying coronary artery disease.
- Increase death occurrences for users with congestive heart failure.
- Elevated blood pressure increases the risk of serious adverse events, such as stroke, heart attack and death.
Sources
Fenfluramine/Pondimin
Issued Warnings/Bans
- 1997 September 15th -- The U.S. FDA see glossary has announced the withdrawal of Fenfluramine. Fenfluramine is marketed under the brand name Pondimin. U.S. FDA has recommended that users to stop taking this drug.
Sources
Potential Health Risks
- Report of cardiac valvular disease (heart disease) in persons who have taken Fenfluramine.
Sources
Add to:
, 
, 
,
,
, 
,
,
